Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma
返回论文页
|更新时间:2023-08-29
|
Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma
Genes & DiseasesVol. 10, Issue 1, (2023)
作者机构:
1. Jiangsu Key Laboratory for Molecular and Medical Biotechnology, School of Life Science, Nanjing Normal University,Jiangsu,Nanjing,China,210023
2. Department of Bioinformatics, Smart Health Big Data Analysis and Location Services Engineering Lab of Jiangsu Province, School of Geographic and Biologic Information, Nanjing University of Posts and Telecommunications,Jiangsu,Nanjing,China,210023
Tingming Liang, Lin Jia, Rui Duan, et al. Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma. [J]. Genes & Diseases 10(1).(2023)
DOI:
Tingming Liang, Lin Jia, Rui Duan, et al. Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma. [J]. Genes & Diseases 10(1).(2023) DOI: 10.1016/j.gendis.2022.02.005.
Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma